SMS Pharmaceuticals Limited (NSE:SMSPHARMA)

SMS Pharmaceuticals Statistics

Total Valuation

NSE:SMSPHARMA has a market cap or net worth of INR 25.24 billion. The enterprise value is 27.93 billion.

Market Cap	25.24B
Enterprise Value	27.93B

Important Dates

The next estimated earnings date is Friday, November 7, 2025.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	Sep 22, 2025

Share Statistics

NSE:SMSPHARMA has 88.65 million shares outstanding. The number of shares has increased by 1.52% in one year.

Current Share Class	88.65M
Shares Outstanding	88.65M
Shares Change (YoY)	+1.52%
Shares Change (QoQ)	+4.79%
Owned by Insiders (%)	52.60%
Owned by Institutions (%)	2.43%
Float	40.35M

Valuation Ratios

The trailing PE ratio is 33.39.

PE Ratio	33.39
Forward PE	n/a
PS Ratio	3.10
PB Ratio	3.95
P/TBV Ratio	3.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	38.19
EV / Sales	3.43
EV / EBITDA	18.91
EV / EBIT	24.82
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.49
Debt / EBITDA	2.15
Debt / FCF	n/a
Interest Coverage	5.54

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	7.72%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	5.54M
Profits Per Employee	497,597
Employee Count	1,197
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:SMSPHARMA has paid 251.38 million in taxes.

Income Tax	251.38M
Effective Tax Rate	25.58%

Stock Price Statistics

The stock price has decreased by -22.22% in the last 52 weeks. The beta is 0.54, so NSE:SMSPHARMA's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	-22.22%
50-Day Moving Average	242.08
200-Day Moving Average	232.66
Relative Strength Index (RSI)	68.66
Average Volume (20 Days)	1,241,945

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:SMSPHARMA had revenue of INR 8.14 billion and earned 731.47 million in profits. Earnings per share was 8.53.

Revenue	8.14B
Gross Profit	2.66B
Operating Income	1.09B
Pretax Income	982.84M
Net Income	731.47M
EBITDA	1.44B
EBIT	1.09B
Earnings Per Share (EPS)	8.53

Balance Sheet

The company has 415.86 million in cash and 3.11 billion in debt, giving a net cash position of -2.69 billion or -30.36 per share.

Cash & Cash Equivalents	415.86M
Total Debt	3.11B
Net Cash	-2.69B
Net Cash Per Share	-30.36
Equity (Book Value)	6.40B
Book Value Per Share	72.15
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 32.71%, with operating and profit margins of 13.40% and 8.98%.

Gross Margin	32.71%
Operating Margin	13.40%
Pretax Margin	12.07%
Profit Margin	8.98%
EBITDA Margin	17.73%
EBIT Margin	13.40%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.14%.

Dividend Per Share	0.40
Dividend Yield	0.14%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-1.52%
Shareholder Yield	-1.38%
Earnings Yield	2.90%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 17, 2015. It was a forward split with a ratio of 10.

Last Split Date	Dec 17, 2015
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	2